MSH6 and neoplasm: The relatively modest numbers of cases in certain groups (e.g., the MSH6-deficient group) and poor availability (and sometimes low quality due to formalin-fixed paraffin-embedded (FFPE)-origin) of tumor samples are among the limitations.